Copyright
©The Author(s) 2015.
World J Pharmacol. Jun 9, 2015; 4(2): 219-226
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.219
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.219
Table 1 Allopatic drugs used for the treatment of ulcerative colitis and their side effects
Drug | Use | Dosage form | Disadvantages | Ref. |
5-aminosalicylic acid compounds | Treatment of tissue inflammation | Enema or orally | Enema solution cannot reach high enough to treat inflammation in the upper colon and if taken orally, however, the stomach and upper small intestine absorb most of the drug before it reaches the colon | [13] |
Sulfasalazine | Decreasing intestinal inflammation and relieving symptoms of abdominal pain, diarrhea, and rectal bleeding | Orally | Nausea, heartburn, headache, anemia, skin rashes, and in rare instances, hepatitis and kidney inflammation. In men, sulfasalazine can reduce the sperm count | [14] |
Olsalazine (consists of two 5-ASA molecules linked together) | Decreasing intestinal inflammation and relieving symptoms of abdominal pain, diarrhea, and rectal bleeding | Orally | Secretory diarrhea | [15] |
Corticosteroids (prednisone, prednisolone, hydrocortisone, etc.) | Corticosteroids do not require direct contact with inflamed intestinal tissues to be effective. These are potent anti-inflammatory agents | Orally, intravenous | Some patients become corticosteroid dependent and consistently develop symptoms of colitis Whenever the corticosteroid dose is below a certain level. Common side effects include rounding of the face (moon face), acne, increased body hair, diabetes, weight gain, high blood pressure, cataracts, glaucoma, increased susceptibility to infections, muscle weakness, depression, insomnia, mood swings, personality changes, irritability, and thinning of bones (osteoporosis) with an accompanying increased risk of compression fractures of the spine. Children on corticosteroids can experience stunted growth | [16] |
Immunomodulator medications | Immunomodulators decrease tissue inflammation by reducing the population of immune cells and/or by interfering with their production of proteins that promote immune activation and inflammation | Orally | Risks of infection due to weakened immunity | [17] |
Azathoprine and 6-Mercaptopurine | These are used mainly in the following situations, UC and CD patients with severe diseases not responding to corticosteroids, patients experiencing undesirable corticosteroid-related side effects, patients dependent on corticosteroids and unable to discontinue them without developing relapses | Increased vulnerability to infections, inflammation of the liver (hepatitis) and pancreas (pancreatitis), and bone marrow toxicity (interfering with the formation of cells that circulate in the blood). 6-MP can reduce the sperm count in men When the partners of male patients on 6-MP conceive, there is a higher incidence of miscarriages and vaginal bleeding. There also are respiratory difficulties in the newborn | [18] | |
Methotrexate | Helpful in treating patients with moderate to severe CD who neither respond to 6-MP and azathioprine nor tolerate these two medications | Orally or intramuscular | Development of liver cirrhosis when the medication is given over a prolonged period of time (years). Low white blood cell counts and inflammation of the lungs. Methotrexate should not be used in pregnancy | [19] |
Cyclosporine | Treatment of severe UC. It is useful in fulminant UC and severely ill patients who do not respond to systemic corticosteroids | Orally as well as intravenously | High blood pressure, renal function impairment, tingling sensations in the extremities, anaphylactic shock and seizures | [20] |
- Citation: Nirmal SA, Gangurde SS, Dumbre PS, Pal SC, Mandal SC. Challenges and opportunities in the treatment of ulcerative colitis. World J Pharmacol 2015; 4(2): 219-226
- URL: https://www.wjgnet.com/2220-3192/full/v4/i2/219.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i2.219